Patents by Inventor John L. XU

John L. XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lymphocyte activation gene-3 (LAG-3) binding antibody and use thereof
    Patent number: 11840568
    Abstract: The present invention relates to an antibody binding to lymphocyte activation gene-3 (LAG-3) and use thereof.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: December 12, 2023
    Assignee: MAB-VENTURE BIOPHARM CO., LTD.
    Inventors: Shaoxiong Wang, John L. Xu, Jing Zhao, Ming Wang, Juehua Xu, Fei Song
  • DUAL TARGETING ANTIGEN BINDING MOLECULE
    Publication number: 20210277121
    Abstract: The present invention is related to a dual targeting antigen binding molecule, a pharmaceutical composition comprising the dual targeting antigen binding molecule and the uses thereof for the treatment of diseases. Additionally, the present invention is also involved in a method for producing the dual targeting antigen binding molecule.
    Type: Application
    Filed: September 29, 2018
    Publication date: September 9, 2021
    Inventors: Shaoxiong WANG, Jing ZHAO, Liming HUANG, Ming WANG, Juehua XU, John L. XU, Shanshan ZOU
  • LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) BINDING ANTIBODY AND USE THEREOF
    Publication number: 20210147536
    Abstract: The present invention relates to an antibody binding to lymphocyte activation gene-3 (LAG-3) and use thereof.
    Type: Application
    Filed: April 1, 2019
    Publication date: May 20, 2021
    Inventors: Shaoxiong WANG, John L. XU, Jing ZHAO, Ming WANG, Juehua XU, Fei SONG